Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
2 Results for "
female mouse model
" in MedChemExpress (MCE) Product Catalog:
Products (2)
2 Results for "female mouse model" in MCE Product Catalog:
Cat. No.: HY-161119
CAS No.: 73326-98-4
Research Areas:
Drpitor1a is an orally active DRP1 GTPase inhibitor. Drpitor1a blocks mitochondrial fission, inhibits DRP1 GTPase activity, and reduces ROS levels. Drpitor1a induces mitochondrial fusion and mitochondria-dependent apoptosis by elevating Bak and Smac/Diablo and inhibiting Bcl-2. Drpitor1a inhibits proliferation in pulmonary arterial hypertension hPASMC and induces necrosis and autophagy mediators. Drpitor1a causes regression of non-small cell lung cancer tumors in mouse xenograft models and exhibits higher accumulation and efficacy in females. Drpitor1a can be used in research related to non-small cell lung cancer, myocardial ischemia-reperfusion injury, and pulmonary arterial hypertension .
Cat. No.: HY-W053722
CAS No.: 147-47-7
Target:
Research Areas:
1,2-Dihydro-2,2,4-trimethylquinoline is a dihydroquinoline (tetrahydroquinoline) derivative. In the NTP carcinogenicity bioassay via the skin route, 1,2-Dihydro-2,2,4-trimethylquinoline shows no evidence of carcinogenicity in the female mouse model, while TOPKAT predicts it to be carcinogenic in that model .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
